NeuroSense Therapeutics L... (NRSNW)
NasdaqCM: NRSNW
· リアルタイム株価 · USD
0.12
+0.00 (0.00%)
終値時点: Aug 05, 2026, 7:48 PM
NeuroSense Therapeutics Ltd. (NRSNW) Stock Price, Analysis & Data
0.00% (1D)
データがありません
NRSNWについて
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and ...
企業情報の全文